Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism.
BACKGROUND
The neurobiological basis for autism remains poorly understood. Given the role of growth factors in brain development, we hypothesized that epidermal growth factor (EGF) may play a role in the pathophysiology of autism. In this study, we examined whether serum levels of EGF are altered in adult subjects with high-functioning autism.


METHODS
We measured serum levels of EGF in the 17 male subjects with high-functioning autism and 18 age-matched healthy male subjects.


RESULTS
The serum levels of EGF in the subjects with high-functioning autism (72.4 +/- 102.8 pg/mL [mean +/- SD]) were significantly lower (Mann-Whitney U = 22.0, p < .001) than those of normal control subjects (322.3 +/- 122.0 pg/mL [mean +/- SD]). However, there were no correlations between serum EGF levels and clinical variables in the subjects with autism.


CONCLUSIONS
This study suggests that decreased levels of EGF might be implicated in the pathophysiology of high-functioning autism.
Suzuki
Katsuaki
K
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Hashimoto
Kenji
K
Iwata
Yasuhide
Y
Nakamura
Kazuhiko
K
Tsujii
Masatsugu
M
Tsuchiya
Kenji J
KJ
Sekine
Yoshimoto
Y
Suda
Shiro
S
Sugihara
Genichi
G
Matsuzaki
Hideo
H
Sugiyama
Toshiro
T
Kawai
Masayoshi
M
Minabe
Yoshio
Y
Takei
Nori
N
Mori
Norio
N
D000328:Adult; D001321:Autistic Disorder / Q000097:blood*; D016022:Case-Control Studies; D004815:Epidermal Growth Factor / Q000097:blood*; D006801:Humans; D008297:Male; D016555:Matched-Pair Analysis; D012016:Reference Values; D012720:Severity of Illness Index
D004815:Epidermal Growth Factor